Scientists scan brains on 'Magic Mushroom' compound
Knowledge-focused
Completed
This early-stage study tested a low-dose form of psilocybin, the compound found in 'magic mushrooms,' in 20 healthy volunteers. Researchers used brain scans (fMRI) to see how the drug affects brain activity and connections. The main goals were to check the drug's safety, how the …
Phase: PHASE1 • Sponsor: MycoMedica Life Sciences PBC • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC